Literature DB >> 14500615

Heterogeneity analysis of the human pituitary proteome.

Xianquan Zhan1, Dominic M Desiderio.   

Abstract

BACKGROUND: A human proteome is relatively dynamic compared with its corresponding genome. Our aim was to study the heterogeneity of a human pituitary proteome as a function of gender, age, and race.
METHODS: Pituitary control tissues (n = 8) were used to extract proteins; each control tissue was analyzed (n = 3-5) with two-dimensional gel electrophoresis (2DGE) and PDQuest software. We obtained 30 high-resolution 2DGE gels and conducted a comparative analysis as a function of gender, age, and race. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry and liquid chromatography-electrospray ionization-quadrupole-ion trap tandem mass spectrometry were used to characterize the protein in each differential spot.
RESULTS: We detected approximately 1000 protein spots in each 2DGE map, and 51 differential spots (7 differing with gender, 17 with age, 15 with race, and 12 with the coeffect of age and race). Among those 51, we characterized 28 proteins [5 differing with gender, 8 with age, 6 with race, 8 with the coeffect of age and race, and 1 (somatotropin chain 1) with all of these]. Somatotropin was related to gender, age, and race, and prolactin was higher in females than males. The differentially expressed proteins that were related to age were mainly those proteins associated with cell growth, proliferation, differentiation, apoptosis, and death; those proteins showed no difference with gender and race. Age and race affected some proteins associated with hormone regulation (e.g., follistatin, thyroid hormone receptor beta-2, adenylate cyclase-inhibiting Galpha protein).
CONCLUSIONS: A heterogeneity exists in the human pituitary proteome as a function of gender, age, and race. These findings will serve as a basis for our comparative proteomics studies of human pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500615     DOI: 10.1373/49.10.1740

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

Review 1.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

2.  Proteomic Analysis of the Human Anterior Pituitary Gland.

Authors:  Soujanya D Yelamanchi; Ankur Tyagi; Varshasnata Mohanty; Pinaki Dutta; Márta Korbonits; Sandip Chavan; Jayshree Advani; Anil K Madugundu; Gourav Dey; Keshava K Datta; M Rajyalakshmi; Nandini A Sahasrabuddhe; Abhishek Chaturvedi; Amit Kumar; Apabrita Ayan Das; Dhiman Ghosh; Gajendra M Jogdand; Haritha H Nair; Keshav Saini; Manoj Panchal; Mansi Ashwinsinh Sarvaiya; Soundappan S Mohanraj; Nabonita Sengupta; Priti Saxena; Pradeep Annamalai Subramani; Pradeep Kumar; Rakhil Akkali; Saraswatipura Vishwabrahmachar Reshma; Ramachandran Sarojini Santhosh; Sangita Rastogi; Sudarshan Kumar; Susanta Kumar Ghosh; Vamshi Krishna Irlapati; Anand Srinivasan; Bishan Das Radotra; Premendu P Mathur; G William Wong; Parthasarathy Satishchandra; Aditi Chatterjee; Harsha Gowda; Anil Bhansali; Akhilesh Pandey; Susarla K Shankar; Anita Mahadevan; T S Keshava Prasad
Journal:  OMICS       Date:  2018-12

3.  Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.

Authors:  Xianquan Zhan; Yuda Huang; Ying Long
Journal:  J Vis Exp       Date:  2018-04-02       Impact factor: 1.355

4.  Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.

Authors:  Dan Liu; Jiajia Li; Na Li; Miaolong Lu; Siqi Wen; Xianquan Zhan
Journal:  EPMA J       Date:  2020-08-13       Impact factor: 6.543

5.  Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.

Authors:  Xianquan Zhan; Chheng-Orn Evans; Nelson M Oyesiku; Dominic M Desiderio
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

6.  Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses.

Authors:  Chheng-Orn Evans; Carlos S Moreno; Xianquan Zhan; Michael T McCabe; Paula M Vertino; Dominic M Desiderio; Nelson M Oyesiku
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 7.  Prognostic indicators in pituitary tumors.

Authors:  Agustinus Suhardja; Kalman Kovacs; Oded Greenberg; Bernd W Scheithauer; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 4.056

8.  Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Xiaowei Wang; Ying Long; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2014-12-24       Impact factor: 3.063

Review 9.  Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Tingting Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-31       Impact factor: 5.555

10.  Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

Authors:  Rong Hu; Xiaowei Wang; Xianquan Zhan
Journal:  EPMA J       Date:  2013-01-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.